Vida Ventures GP III, L.L.C.
CIK: 0001855502
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Sep 12, 2025LBRX
LB PHARMACEUTICALS INC
Conversion(C)Indirect547.6K shares- - Sep 12, 2025LBRX
LB PHARMACEUTICALS INC
Conversion(C)Indirect1.3K shares- - Sep 12, 2025LBRX
LB PHARMACEUTICALS INC
Purchase(P)Indirect332.6K shares at avg. $15.00$5.0M - Sep 12, 2025LBRX
LB PHARMACEUTICALS INC
Purchase(P)Indirect767 shares at avg. $15.00$12K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 12, 2025 |  LBRX LB PHARMACEUTICALS INC | Conversion(C) | 547,648 | - | - | Indirect |
| Sep 12, 2025 | LBRX LB PHARMACEUTICALS INC | Conversion(C) | 1,262 | - | - | Indirect |
| Sep 12, 2025 | LBRX LB PHARMACEUTICALS INC | Purchase(P) | 332,566 | $15.00 | $4,988,490 | Indirect |
| Sep 12, 2025 | LBRX LB PHARMACEUTICALS INC | Purchase(P) | 767 | $15.00 | $11,505 | Indirect |
1-4 of 4 transactions
About Vida Ventures GP III, L.L.C.
Vida Ventures GP III, L.L.C. (SEC CIK 0001855502) files insider reports with the SEC as 10% Owner of Attovia Therapeutics, Inc. (ATTO) and 10% Owner of LB PHARMACEUTICALS INC (LBRX).
Signal8 holds 3 ownership filings by Vida Ventures GP III, L.L.C. (2 Form 3, 1 Form 4), filed between Sep 10, 2025 and Aug 4, 2026. Those filings report 4 transactions, the latest on Sep 12, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Vida Ventures GP III, L.L.C.'s filings is in LOS ANGELES, CA.
Recent filings by Vida Ventures GP III, L.L.C.
Other insiders filing for Attovia Therapeutics, Inc. (ATTO)
- Fu Tao, President and CEO
- Chan Steven, Chief Financial Officer
- WALSH COLIN, Director
- GOLDMAN SACHS GROUP INC, Officer
- Deep Track Biotechnology Master Fund, Ltd., 10% Owner
- venBio Global Strategic Fund IV, L.P., 10% Owner